21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements
Food and Drug Administration (FDA)
· published 2007-06-25
Research Pending
Awaiting research outcome
AI Failures: Hallucination and Blind Spots Shape
(0 Response Hallucination + 0 Citation Hallucination + 0 Blind Spots = 0 Failure Mode Findings)
Citation Hallucination Modes (0 failures)
Fabricated
0
Pretextual
0
Contradictory
0
AI Blind Spots (0 failures)
Web Retrieval
0
Training Knowledge
0
Hallucination findings
No published hallucination findings yet for this regulation. Research is queued or in progress.
AI Blind Spots
No AI Blind Spots documented for this regulation yet.